Valuation: Abbott India Limited

Market Cap 590B 6.18B 5.38B 5B 4.59B 8.68B 8.81B 58.99B 23.15B 294B 23.23B 22.72B 986B P/E 2027 *
34.6x
P/E 2028 * 30.7x
Enterprise Value 567B 5.93B 5.16B 4.8B 4.41B 8.33B 8.45B 56.6B 22.22B 282B 22.29B 21.8B 946B EV / Sales 2027 *
7.55x
EV / Sales 2028 * 6.85x
Free-Float
24.45%
Yield 2027 *
2.08%
Yield 2028 * 2.24%
1 day+0.79%
1 week-0.78%
1 month+8.67%
3 months+9.25%
6 months+1.75%
Current year-4.42%
1 week 27,450.45
Extreme 27450.45
28,109.9
1 month 25,632.05
Extreme 25632.05
29,250
Current year 25,164
Extreme 25164
29,250
1 year 25,164
Extreme 25164
34,220
3 years 21,907.45
Extreme 21907.45
35,921.55
5 years 15,525
Extreme 15525
35,921.55
10 years 3,996
Extreme 3996
35,921.55
Manager TitleAgeSince
Chief Executive Officer 46 2025-06-13
Director of Finance/CFO 52 2025-05-05
Director of Finance/CFO - 2025-03-31
Director TitleAgeSince
Chairman 83 1967-12-31
Director/Board Member 69 2011-02-28
Director/Board Member 71 2019-03-31
Change 5-day change 1-year change 3-year change Capi.($)
+0.79%-0.78%-17.50%+16.09% 6.18B
-0.53%-3.95%+50.70%+153.56% 1,024B
+0.21%-2.68%+53.20%+51.79% 618B
-2.51%-3.25%+28.54%+68.94% 443B
+0.06%-0.42%+37.53%+30.67% 349B
-0.69%-0.30%+13.76%+12.83% 264B
-7.37%-4.40%-0.74%-44.28% 209B
-0.64%+2.43%+29.74%+65.93% 208B
-0.82%+0.70%+15.05%+72.05% 162B
+0.40%+1.92%+6.47%-29.77% 143B
Average -1.11%-1.17%+21.68%+39.78% 342.51B
Weighted average by Cap. -1.00%-2.01%+36.05%+71.80%

Financials

2027 *2028 *
Net sales 75.09B 787M 684M 636M 584M 1.1B 1.12B 7.5B 2.94B 37.38B 2.95B 2.89B 125B 82.25B 862M 749M 697M 640M 1.21B 1.23B 8.22B 3.22B 40.95B 3.24B 3.16B 137B
Net income 17.05B 179M 155M 145M 133M 251M 255M 1.7B 669M 8.49B 671M 656M 28.47B 19.12B 200M 174M 162M 149M 281M 285M 1.91B 750M 9.52B 752M 736M 31.91B
Net Debt -23.86B -250M -217M -202M -186M -351M -356M -2.38B -935M -11.88B -939M -918M -39.83B -26.92B -282M -245M -228M -210M -396M -402M -2.69B -1.06B -13.4B -1.06B -1.04B -44.94B
Logo Abbott India Limited
Abbott India Limited is an India-based pharmaceutical company. The Company is involved in product development, manufacturing, sales, and customer service. It distributes products and solutions in multiple therapeutic categories, such as women's health, gastroenterology, cardiology, metabolic disorders and primary care. It operates in a single reportable business segment, which is Pharmaceuticals. The Company’s products include Arachitol Nano, Digeraft, Influvac, Colospa, Duphalac, Librax, Creon, Duphaston, Prothiaden, Cremaffin, Duvadilan, Thyronorm, Cremaffin Plus, Ganaton, Udiliv, Digene, Heptral, Vertin, Zolfresh, Citrosoda UTI, Digene Insta On The Go, Digeraft tablet, Duphaston OD, Pneumoshield 14, Prothiaden Neu, Vonefi, Levesam, and LOBATE M Skin Cream, among others. The Company sells its products through independent distributors primarily within India.
Employees
3,679
Date Price Change Volume
26-07-31 ₹27,784.15 +0.79% 413
26-07-30 ₹27,566.00 -0.56% 384
26-07-29 ₹27,720.05 -0.67% 812
26-07-28 ₹27,907.05 +0.34% 1,011
26-07-27 ₹27,813.40 -0.68% 444
Trader
Investor
Global
-
Quality
ESG MSCI
-

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ABBOTINDIA Stock